Tris Pharma, a Pfizer CMO, warned by FDA

The U.S. FDA sent a Warning Letter to Tris Pharma, a CMO that manufacturers ADHD drug, Quillivant, for Pfizer, citing significant violations of CGMP regulations.Original Article